Laboratory 15min Troponin I Rapid Test Kit Myoglobin Rapid Antigen Test Kit

Myoglobin Detection Reagent(MYO)(Immunofluorescence Chromatography) Clinical Significance

MYO Overview

Myoglobin (MYO) is a hemoglobin that is present in cardiac muscle and skeletal muscle cytoplasm and is not present in smooth muscle. Myoglobin can be detected in the blood 1-2 hours after the onset of AMI, which is one of the earliest markers representing the elevation of myocardial injury. Myo is abundant in myocardium and skeletal muscle, and is quickly released into the blood during AMI. It is highly sensitive to AMI

MYO performance index

MYO Three-level structure

The myoglobin molecule is a flat prism with a molecular size of about 4.5mm×3.5mm×2.5m. The polypeptide backbone in the molecule is composed of 8 straight a-helices of varying lengths. The longest helix contains 23 residues and the shortest 7 residues. Almost 80% of the amino acid residues in the molecule are in the α-helix region. . These 8 spirals are named A, B, C...H respectively. The corresponding non-helical region peptides are called NA (terminal section), AB, BC,...FG, GH, HC (C-terminal section). Therefore, each residue has a sequence number calculated from the N-terminus. In addition to the position in each helical segment, an additional number is given. For example, the 93rd His is coded as F8, which means that His is at the 8th position of the F helix.

MYO Clinical significance

• Early AMI excludes the most important and sensitive indicators
• Recurrent diagnosis of AMI, the best index of reperfusion treatment effect evaluation

Application Department

Cardiology, emergency, laboratory, pediatrics, hematology, oncology, Nephrology, surgery, etc

MYO Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.